How strong is the evidence? How clear are the conclusions?

被引:40
作者
Ezzo, J
Bausell, B
Moerman, DE
Berman, B
Hadhazy, V
机构
[1] Univ Maryland, Sch Med, Epidemiol Fac, Project LEAD, Baltimore, MD 21209 USA
[2] Univ Maryland, Sch Med, Program Complementary Med, Baltimore, MD 21207 USA
[3] Univ Michigan, Dearborn, MI 49128 USA
[4] Social & Sci Syst, Rockville, MD 20852 USA
关键词
evidence-based medicine; review literature; outcomes assessment (health care); metaanalysis; randomized controlled trials;
D O I
10.1017/S0266462301107014
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: The objectives of this paper were: a) to determine what can be learned from conclusions of systematic reviews about the evidence base of medicine; and b) to determine whether two readers draw similar conclusions from the same review, and whether these match the authors' conclusions. Methods: Three methodologists (two per review) rated 160 Cochrane systematic reviews (issue 1, 1998) using pre-established conclusion categories. Disagreements were resolved by discussion to arrive at a consensual score for each review. Reviews' authors were asked to use the same categories to designate the intended conclusion. Interrater agreements were calculated. Results: Interrater agreement between two readers was 0.68 and 0.72, and between readers and authors, 0.32. The largest categories assigned by methodologists were "positive effect" (22.5%), "insufficient evidence" (21.3%), and "evidence of no effect" (20.0%). The largest categories assigned by authors were "insufficient evidence" (32.4%), "possibly positive" (28.6%), and "positive effect" (26.7%). Conclusions: The number of reviews indicating that the modern biomedical interventions show either no effect or insufficient evidence is surprisingly high. Intterrater disagreements suggest a surprising degree of subjective interpretation involved in systematic reviews. Where patterns of disagreement emerged between authors and readers, authors tended to be more optimistic in their conclusions than the readers. Policy implications are discussed.
引用
收藏
页码:457 / 466
页数:10
相关论文
共 26 条
[1]  
AVEYARD P, 1995, LANCET, V346, P840
[2]   AFTER THE META-ANALYTIC REVOLUTION [J].
BAUSELL, RB .
EVALUATION & THE HEALTH PROFESSIONS, 1993, 16 (01) :3-12
[3]   How consumers and policymakers can use systematic reviews for decision making [J].
Bero, LA ;
Jadad, AR .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (01) :37-42
[4]  
CHERKIN D, 1997, NIH CONS C AC BETH M
[5]  
Clarke M, 1998, LANCET, V351, P1451
[6]   The Cochrane Collaboration: Evaluation of health care and services using systematic reviews of the results of randomized controlled trials [J].
Dickersin, K ;
Manheimer, E .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1998, 41 (02) :315-331
[7]   FACTORS INFLUENCING PUBLICATION OF RESEARCH RESULTS - FOLLOW-UP OF APPLICATIONS SUBMITTED TO 2 INSTITUTIONAL REVIEW BOARDS [J].
DICKERSIN, K ;
MIN, YI ;
MEINERT, CL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (03) :374-378
[8]   INPATIENT GENERAL MEDICINE IS EVIDENCE BASED [J].
ELLIS, J ;
MULLIGAN, I ;
ROWE, J ;
SACKETT, DL .
LANCET, 1995, 346 (8972) :407-410
[9]   AN INQUIRY INTO THE DRUG BILL [J].
FORSYTH, G .
MEDICAL CARE, 1963, 1 (01) :10-16
[10]   MULTIPLE PUBLICATION OF REPORTS OF DRUG TRIALS [J].
GOTZSCHE, PC .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (05) :429-432